Recently, Maersk and MGI Tech held a strategic cooperation signing ceremony in Shenzhen.
At present, Maersk and MGI Tech have cooperation in the fields of air, ocean shipping, inland transport services, overseas warehousing and distribution. The signing of the strategic cooperation agreement will facilitate the future cooperation between the two sides in maritime transportation services, cold chain logistics, overseas warehousing, customs declaration and related consulting services, as well as low-carbon transportation and digital solutions and other broader logistics and supply chain areas.
MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. With a focus on R&D, production and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and full-life-cycle equipment and systems for precision medicine, precision agriculture, precision healthcare and other relevant industries. Founded in 2016, MGI operates in more than 80 countries and regions, serving more than 1,300 customers. MGI is one of the few companies in the world that can independently develop and mass-produce clinical high-throughput gene sequencers.
At present, Maersk and MGI Tech have cooperation in the fields of air, ocean shipping, inland transport services, overseas warehousing and distribution. The signing of the strategic cooperation agreement will facilitate the future cooperation between the two sides in maritime transportation services, cold chain logistics, overseas warehousing, customs declaration and related consulting services, as well as low-carbon transportation and digital solutions and other broader logistics and supply chain areas.
MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. With a focus on R&D, production and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and full-life-cycle equipment and systems for precision medicine, precision agriculture, precision healthcare and other relevant industries. Founded in 2016, MGI operates in more than 80 countries and regions, serving more than 1,300 customers. MGI is one of the few companies in the world that can independently develop and mass-produce clinical high-throughput gene sequencers.
The opinions expressed herein are the author's and not necessarily those of The Xinde Marine News.
Please Contact Us at：
media@xindemarine.com
